ES2033076T3 - Composiciones farmaceuticas que tienen actividad endotoxica. - Google Patents

Composiciones farmaceuticas que tienen actividad endotoxica.

Info

Publication number
ES2033076T3
ES2033076T3 ES198989201329T ES89201329T ES2033076T3 ES 2033076 T3 ES2033076 T3 ES 2033076T3 ES 198989201329 T ES198989201329 T ES 198989201329T ES 89201329 T ES89201329 T ES 89201329T ES 2033076 T3 ES2033076 T3 ES 2033076T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
endotoxic activity
endotoxic
activity
sytup
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989201329T
Other languages
English (en)
Inventor
Maarten H. Cno Octrooibureau Zoan B.V. Pranger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duphar International Research BV
Original Assignee
Duphar International Research BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar International Research BV filed Critical Duphar International Research BV
Application granted granted Critical
Publication of ES2033076T3 publication Critical patent/ES2033076T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/04—Disaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A COMPOSICIONES FARMACEUTICAS CON ACTIVIDAD ANTI - ENDOTOXICA COMPRENDIENDO COMO COMPONENTE ACTIVO UNA FRACCION QUE PUEDE SER AISLADA DE SIROPE DE LACTULASA POR MEDIO DE ABSORCION EN UNA RESINA CATIONICA DE POLIESTIRENO SULFONADO EN LA FORMA CA 2+ Y ELUCION CON UN DISOLVENTE CONVENIENTE. EL SIROPE DE LACTULOSA PUEDE SER OBTENIDO POR ISOMERIZACION BASICA DE LACTOSA A TEMPERATURA ELEVADA, OPCIONALMENTE EN LA PRESENCIA DE SULFITO SODICO.
ES198989201329T 1988-05-26 1989-05-24 Composiciones farmaceuticas que tienen actividad endotoxica. Expired - Lifetime ES2033076T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8801349 1988-05-26

Publications (1)

Publication Number Publication Date
ES2033076T3 true ES2033076T3 (es) 1993-03-01

Family

ID=19852354

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989201329T Expired - Lifetime ES2033076T3 (es) 1988-05-26 1989-05-24 Composiciones farmaceuticas que tienen actividad endotoxica.

Country Status (12)

Country Link
US (1) US5128323A (es)
EP (1) EP0345850B1 (es)
JP (1) JPH0219319A (es)
AT (1) ATE81590T1 (es)
AU (1) AU612843B2 (es)
DE (1) DE68903246T2 (es)
DK (1) DK249789A (es)
ES (1) ES2033076T3 (es)
GR (1) GR3006759T3 (es)
IL (1) IL90388A (es)
NZ (1) NZ229247A (es)
ZA (1) ZA893944B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034064A (en) * 1988-09-01 1991-07-23 Snow Brand Milk Products Co., Ltd. Production process of high-purity lactulose syrup
AU660325B2 (en) * 1991-10-11 1995-06-22 Eisai Co. Ltd. Anti-endotoxin compounds and related molecules and methods
RU2113466C1 (ru) * 1997-02-28 1998-06-20 Николай Яковлевич Дыкало Способ обработки алкогольных напитков
US6290946B1 (en) 1999-05-13 2001-09-18 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders and antibacterial agents
US6270755B1 (en) 1999-05-13 2001-08-07 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders
CA2314494A1 (en) 2000-05-02 2001-11-02 Geltex Pharmaceuticals, Inc. Anionic polymers as species specific antibacterial agents
EP1542706A1 (en) * 2002-07-22 2005-06-22 Genzyme Corporation Poly (potassium and sodium styrene sulfonate), its manufacture and its uses

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2524414A (en) * 1946-06-26 1950-10-03 Univ Ohio State Res Found Chromatographic separation of carbohydrates
JPS522984B1 (es) * 1971-05-22 1977-01-25
GB1501700A (en) * 1975-10-02 1978-02-22 Portals Water Treatment Ltd Lactose hydrolysis using ion exchange resins
US4536221A (en) * 1982-12-17 1985-08-20 Sirac Spa Process for preparing lactulose from lactose, in the form of a syrup or a crystalline product
IT1163540B (it) * 1983-06-20 1987-04-08 Sirac Srl Procedimento per la purificazione dello sciroppo di lattulosio
IT1206140B (it) * 1984-03-22 1989-04-14 Sirac Srl Procedimento per la purificazione di lattulosio.
IT1223398B (it) * 1987-12-01 1990-09-19 Sirac Spa Procedimento per la preparazione di lattulosio cristallino ad alta purezza
IT1235866B (it) * 1987-12-01 1992-11-23 Sirac Srl Processo per la preparazione di lattolosio da lattosio mediante epimerizzazione con alluminato sodico
IT1224438B (it) * 1987-12-30 1990-10-04 Sirac Srl Processo per l'ottenimento di sciroppi di lattulosio ad elevata purezza e sciroppo cosi' ottenuto
US4931554A (en) * 1988-02-22 1990-06-05 Duphar International Research B.V. Method of preparing a solid composition of lactulose, and composition so obtained

Also Published As

Publication number Publication date
ATE81590T1 (de) 1992-11-15
JPH0219319A (ja) 1990-01-23
DK249789D0 (da) 1989-05-23
NZ229247A (en) 1991-06-25
GR3006759T3 (es) 1993-06-30
EP0345850B1 (en) 1992-10-21
AU612843B2 (en) 1991-07-18
AU3515789A (en) 1989-11-30
ZA893944B (en) 1990-02-28
US5128323A (en) 1992-07-07
IL90388A (en) 1993-08-18
IL90388A0 (en) 1989-12-15
DE68903246D1 (de) 1992-11-26
DK249789A (da) 1989-11-27
DE68903246T2 (de) 1993-03-11
EP0345850A1 (en) 1989-12-13

Similar Documents

Publication Publication Date Title
IT1227898B (it) Composizione microincapsulata per il controllo delle blatte
ES547528A0 (es) Procedimiento de preparacion de hanitol granular.
DK162443C (da) 1,3-diacyl-2-oxindol-forbindelser samt 1-acyl-2-oxindol-forbindelser til anvendelse som mellemprodukter ved deres fremstilling
DK19887D0 (da) Peptider med vasorelaxerende, natriuretisk og diuretisk virkning, fremgangsmaade til deres fremstiling, midler indeholdende forbindelserne og deres anvendelse
ES2033076T3 (es) Composiciones farmaceuticas que tienen actividad endotoxica.
DK539087A (da) 4,5-dihydro- og 4,5,6,7-tetrahydro-pyrazolooe1,5-aaapyrimidiner, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK170986A (da) Substituerede 2,3,4,9-tetrahydro-1h-carbazol-1-eddikesyre-derivater, deres fremstilling og anvendelse som famaceutika samt mellem-produkter ved fremstillingen
DK135988A (da) 2,5-dihydropyrroler, fremgangsmaader til deres fremstilling samt deres anvendelse som herbicider
DK354188D0 (da) Guanidinothiazolforbindelse, fremgangsmaade til d eres fremstilling samt anvendelsen heraf som mellemprodukt i famotidinprocessen
DK69493D0 (da) Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-1-eddikesyreestere samt fremgangsmaade til fremstilling deraf
Milbert et al. ADJUST: The horizontal observation adjustment program
IT8105250A0 (it) Dispositivo di fermo adatto per fissare la posizione, rispetto al pavimento, di sedie con rotelle.
DK401988A (da) 11-substituerede 5-aryl-5h,11h-pyrrolo(2,1-c)-(1,4)benzoxazepiner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
Ecker Area-minimizing integral currents with movable boundary parts of prescribed mass
DK0387568T3 (da) Substituerede 1,8-naphthyridiner, fremgangsmåde til deres fremstilling og deres anvendelse som antidoter
IT8421715A1 (it) Impianto per la schiumatura in particolare di mobili frigoriferi
IT9012431A0 (it) Dispositivo per il collegamento amovibile di due mobili per sedersi disposti affiancati
Brooks Direct investment by the state; mixed enterprise in Canada.
BR8600328A (pt) Composicao inseticida que libera seletivamente os compostos ativos nela presentes
Bassingthwaite-Thiessen The choice of site for childbirth as related to selected issues of control
DK346387D0 (da) Fremgangsmaade til at reducere alkaliindholdet i cementklinker
DK570388D0 (da) Pyridylphosphater, fremgangsmaade til deres fremstilling samt deres anvendelse som pesticider
ENDO Materials Concerning the Boundary of Fishing Ground in Meiji Era
Flores d'Arcais et al. Max-Planck-Institute for Psycholinguistics: Annual Report Nr. 8 1987
Alfheim Quantitative analysis of formaldehyde by use of the thermal lens effect

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 345850

Country of ref document: ES